| Description | GABRA2 Human Pre-designed siRNA Set A contains three designed siRNAs for GABRA2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control. Components GABRA2 siRNA-1: 5 nmol (HPLC) GABRA2 siRNA-2: 5 nmol (HPLC) GABRA2 siRNA-3: 5 nmol (HPLC) siRNA Negative GABRA2 Human Pre-designed siRNA Set A contains three designed siRNAs for GABRA2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control. Components GABRA2 siRNA-1: 5 nmol (HPLC) GABRA2 siRNA-2: 5 nmol (HPLC) GABRA2 siRNA-3: 5 nmol (HPLC) siRNA Negative Control: 5 nmol (HPLC) FAM-labeled siRNA Negative Control: 5 nmol (HPLC) GAPDH siRNA Positive Control:5 nmol (HPLC)... Read More | The Leuconostoc GPDH exhibits dual coenzyme specificity, namely NAD and NADP (Olive and Levy, Biochem., 6, 730 730, 1967). When assayed under conditions that are optimal for the particular coenzyme, the ratio of observed catalytic activity is NAD/NADP = 1.8 | Inquire | Biochemical Test:SDS-PAGE (purity > 80%); Western blot with patient sample.Calculated Isoelectric Point:pH 5.68 | Purity: >90%, by SDS-PAGE visualized with Coomassie® Blue Staining. Description: Major histocompatibility complex, class II, DR alpha (HLA-DRA) belongs to the MHC class II family. HLA-DRA binds peptides derived from antigens which access the endocytic route of antigen presenting cells (APC) Purity: >90%, by SDS-PAGE visualized with Coomassie® Blue Staining. Description: Major histocompatibility complex, class II, DR alpha (HLA-DRA) belongs to the MHC class II family. HLA-DRA binds peptides derived from antigens which access the endocytic route of antigen presenting cells (APC) and presents them on the cell surface for identification by the CD4 T-cells. The peptide binding cleft accommodates peptides of 10-30 residues. The peptides presented by MHC class II molecules are generated mainly by degradation of proteins which access the endocytic route, where they are processed by lysosomal proteases and other hydrolases... Read More |